Evidence map›Paper›PMID 18719122›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Mass spectrometry-based discovery of circadian peptides.

Nathan G Hatcher, Norman Atkins, Suresh P Annangudi, Andrew J Forbes, Neil L Kelleher, Martha U Gillette, Jonathan V Sweedler

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Secreted Chaperones in Neurodegeneration.Frontiers in aging neuroscience · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Exploring the Sea Urchin Neuropeptide Landscape by Mass Spectrometry.Journal of the American Society for Mass Spectrometry · 2018
    Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Nathan G HatcherDepartment of Chemistry, University of Illinois, Urbana, IL 61801, USA.
Norman Atkins
Suresh P Annangudi
Andrew J Forbes
Neil L Kelleher
Martha U Gillette
Jonathan V Sweedler
University of Illinois Urbana-Champaign · USDivision of Chemistry · USSociety for Neuroscience · US

Funding

The UIUC Neuroproteomics Center on Cell-Cell SignalingP30DA018310 · NIDA · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI Elena V Romanova · 2004 to 2026
$24.9M
Actin-based Neuronal State ChangesR01HL086870 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI GILLETTE, MARTHA U · 2007 to 2010
$1.6M
NEUROPEPTIDES IN THE CNS WITH NEW MASS SPECTROMETRIC SAMPLING PROTOCOLSR01DA017940 · NIDA · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI SWEEDLER, JONATHAN V. · 2006 to 2010
$1.1M
NHLBI NIH HHS R01 HL086870NIDA NIH HHS P30 DA 018310NIDA NIH HHS P30 DA018310NIDA NIH HHS R01 DA 017940NIDA NIH HHS R01 DA017940
6 · The paper itself

Abstract

A significant challenge to understanding dynamic and heterogeneous brain systems lies in the chemical complexity of secreted intercellular messengers that change rapidly with space and time. Two solid-phase extraction collection strategies are presented that relate time and location of peptide release with mass spectrometric characterization. Here, complex suites of peptide-based cell-to-cell signaling molecules are characterized from the mammalian suprachiasmatic nucleus (SCN), site of the master circadian clock. Observed SCN releasates are peptide rich and demonstrate the co-release of established circadian neuropeptides and peptides with unknown roles in circadian rhythms. Additionally, the content of SCN releasate is stimulation specific. Stimulation paradigms reported to alter clock timing, including electrical stimulation of the retinohypothalamic tract, produce releasate mass spectra that are notably different from the spectra of compounds secreted endogenously over the course of the 24-h cycle. In addition to established SCN peptides, we report the presence of proSAAS peptides in releasates. One of these peptides, little SAAS, exhibits robust retinohypothalamic tract-stimulated release from the SCN, and exogenous application of little SAAS induces a phase delay consistent with light-mediated cues regulating circadian timing. These mass spectrometry-based analyses provide a new perspective on peptidergic signaling within the SCN and demonstrate that the integration of secreted compounds with information relating time and location of release generates new insights into intercellular signaling in the brain.

Indexed as

Circadian RhythmAnimalsElectric StimulationElectrophysiologyMass SpectrometryNerve Tissue ProteinsNeuropeptidesPeptide FragmentsProteomicsRatsRats, Long-EvansSignal TransductionSolid Phase ExtractionSuprachiasmatic NucleusNerve Tissue ProteinsNeuropeptidesPeptide Fragments

Identifiers

PMID18719122
PMCPMC2518830
OpenAlexW2020662717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.